检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:路阳[1] 席峰[1] 郭阿娟[1] 陆晨[1] 李士雪[2]
机构地区:[1]新疆维吾尔自治区人民医院医务部, 新疆维吾尔自治区乌鲁木齐830001 [2] 山东大学公共卫生学院社会医学与卫生事业管理研究所
出 处:《中国基层医药》2014年第2期168-170,共3页Chinese Journal of Primary Medicine and Pharmacy
基 金:新疆维吾尔自治区“十二五”重大科技专项课题(201230119-1)
摘 要:目的 探索以实施临床路径为契机,实行主要住院指标考核的方法.方法 根据2008-2010年3年的基线资料,参考省(自治区)内同级医院的数据,设定基准值,制定考核标准,对临床科室实行平均住院日、次均住院费用、药品比例三项指标的考核,并采取分项奖励措施,根据较基准值下降的比率每月给予相应奖励.结果 全院和临床科室的平均住院日、次均住院费用、药品比例三项指标较上年同期均下降,且差异有统计学意义(内科系统:t=27.479、14.462、11.362,均P<0.01;外科系统:t=18.944、16.029、12.071,均P<0.01).结论 实行主要住院指标考核,与实施临床路径相结合,可有效缩短平均住院日,降低次均住院费用和药品比例,减轻患者经济负担.Objective To explore the method of the major hospital indexes examination using clinical pathway as an opportunity.Methods Based on the material of our hospital from 2008 to 2010,reference the data of the same level hospital in Xinjiang Uygur Autonomous Region,we set the benchmark and formulated the examination standard of three examination indexes:average length of stay (ALOS),average hospitalization expense and drug proportion.Meanwhile,we took the subentry incentives to give the corresponding reward to clinical departments according to the decreases rate compared with the benchmark monthly.Results ALOS,average hospitalization expense and drug proportion of department and the whole hospital were obviously decreased compared with the same period last year,and the differences were statistically significant (Medical system:t =27.479,14.462,11.362,all P 〈 0.01 ; Surgical system:t =18.944,16.029,12.071,all P 〈 0.01).Conclusion After using the examination methods and combining clinical pathway,the effects are obvious,which can effectively shorten ALOS,reduce average hospitalization expense and drug proportion,so as to relieve the patients' economic burden.
关 键 词:临床路径 平均住院日 次均住院费用 药品比例 考核
分 类 号:R197.32[医药卫生—卫生事业管理]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.30